Tuberculosis Strain: Definition, Types and Resistance
A tuberculosis strain is a specific genetic variant of the bacterium Mycobacterium tuberculosis, which causes the infectious disease tuberculosis.
Things worth knowing about "Tuberculosis strain"
A tuberculosis strain is a specific genetic variant of the bacterium Mycobacterium tuberculosis, which causes the infectious disease tuberculosis.
What is a Tuberculosis Strain?
A tuberculosis strain refers to a genetically defined variant of the bacterium Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Within the species Mycobacterium tuberculosis, numerous genetically distinct strains exist that can differ in their virulence, geographic distribution, transmissibility, and resistance to antibiotics. Accurate characterization of a tuberculosis strain is of central importance for epidemiology, treatment, and infection control.
Biological Basics
Mycobacterium tuberculosis is a slow-growing, acid-fast rod-shaped bacterium. It belongs to the Mycobacterium tuberculosis complex (MTBC), which also includes related species such as M. bovis, M. africanum, and M. canettii. All members of this complex can cause tuberculosis in humans, though M. tuberculosis is responsible for the vast majority of cases.
The genetic diversity within M. tuberculosis is captured by modern methods such as whole-genome sequencing (WGS), MIRU-VNTR typing, and spoligotyping. These techniques allow researchers to trace transmission chains and analyze global distribution patterns.
Major Strain Lineages
Several major phylogenetic lineages are distinguished worldwide:
- Lineage 1: Indo-Oceanic lineage, prevalent in South Asia and East Africa
- Lineage 2: East Asian lineage, known as the Beijing lineage; associated with increased virulence and resistance development
- Lineage 3: Delhi/CAS lineage, prevalent in Central Asia and East Africa
- Lineage 4: Euro-American lineage, the most widespread group globally
- Lineage 5 and 6: West African lineages (M. africanum)
- Lineage 7: Ethiopian lineage
Resistance Development and Drug-Resistant Strains
A particularly important characteristic of certain tuberculosis strains is the development of antibiotic resistance. Key categories include:
- MDR-TB (Multidrug-Resistant Tuberculosis): Resistance to the two most important first-line antibiotics, isoniazid and rifampicin
- XDR-TB (Extensively Drug-Resistant Tuberculosis): Additional resistance to fluoroquinolones and at least one second-line injectable drug
- Pre-XDR-TB: A newer classification according to WHO 2021, including resistance to rifampicin plus fluoroquinolones
Resistance arises through spontaneous genetic mutations in the bacterial genome and is selected by incomplete or inadequate treatment. Certain strains, particularly the Beijing strain, show a heightened tendency toward resistance development.
Transmission and Epidemiology
Tuberculosis is transmitted from person to person via aerosols (airborne droplet nuclei). The characteristics of a particular strain can influence its transmissibility and the clinical course of the disease. According to the WHO, tuberculosis remains one of the leading infectious causes of death worldwide. In 2023, an estimated 10.8 million people were newly diagnosed with tuberculosis globally.
Diagnosis and Strain Typing
Identification of a tuberculosis strain involves:
- Culture and microscopic examination
- Drug susceptibility testing (phenotypic and genotypic)
- Molecular typing: MIRU-VNTR, spoligotyping, whole-genome sequencing (WGS)
- PCR-based rapid tests such as GeneXpert MTB/RIF for rapid detection of rifampicin resistance
Strain typing is essential not only for clinical treatment but also for public health and the tracing of transmission chains.
Treatment
Treatment is guided by the resistance profile of the specific strain:
- Drug-susceptible TB: Standard therapy with isoniazid, rifampicin, pyrazinamide, and ethambutol over 6 months
- MDR-TB: Longer treatment regimens using reserve antibiotics such as bedaquiline, linezolid, and clofazimine
- XDR-TB / Pre-XDR-TB: Individualized treatment using newer agents in accordance with current WHO guidelines
References
- World Health Organization (WHO): Global Tuberculosis Report 2023. Geneva: WHO, 2023. Available at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
- Coscolla M, Gagneux S. Consequences of genomic diversity in Mycobacterium tuberculosis. Semin Immunol. 2014;26(6):431-444. PubMed PMID: 25453224.
- Pai M, Behr MA, Dowdy D, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076. PubMed PMID: 27784885.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.